BioCentury
ARTICLE | Company News

U.K. approves ketoprofen/omeprazole combination

December 10, 2008 1:21 AM UTC

Meda (SSE:MEDA) said the U.K. approved the company's ketoprofen/ omeprazole combination product to treat pain and inflammation. The combination of an NSAID and a proton pump inhibitor (PPI) is under r...